STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further… Read More
Brand Name Drug Companies Applying Price-Hiking, Patent Abuse Playbook to… Read More
Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing… Read More
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on… Read More
Analysis Shows Price Hikes Outpacing Inflation, Rising Launch Prices and… Read More
Reports Find Biosimilars Have Lower Prices Than Brand Name Biologics… Read More
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More